STOCK TITAN

TACTILE SYSTEMS TECHNOLOGY INC (TCMD) SEC Filings, Feb-May 2026

TCMD NASDAQ

Welcome to our dedicated page for TACTILE SYSTEMS TECHNOLOGY SEC filings (Ticker: TCMD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tactile Systems Technology, Inc. filings document a Nasdaq-listed medical technology issuer with common stock registered under the ticker TCMD. Recent Form 8-K reports disclose quarterly and annual operating results, financial condition updates, acquisition-related Regulation FD materials, FDA and product-related business highlights, share repurchase authorization activity and other corporate events.

The company's proxy and governance filings cover board composition, director elections, committee assignments, executive compensation, shareholder voting matters and amendments to its certificate of incorporation. Its SEC disclosures also identify Delaware incorporation, Nasdaq listing status, capital actions and governance provisions relevant to its public-company structure.

Rhea-AI Summary

Tactile Systems Technology, Inc. reported a strong first quarter of 2026, with total revenue rising 23% to $75.3 million from $61.3 million a year earlier. Growth was broad-based, as lymphedema product revenue increased to $62.2 million and airway clearance revenue rose to $13.0 million, each maintaining 83% and 17% of total sales.

Gross profit grew 27% to $57.6 million and gross margin improved to 76.5%. Operating loss narrowed to $1.5 million and net loss improved to $1.8 million, or $0.08 per diluted share. Adjusted EBITDA swung to a positive $3.7 million from a small loss, helped by higher revenue and operating leverage.

As of March 31, 2026, the company held $75.0 million in cash with no borrowings and repurchased $1.1 million of stock. Management raised its 2026 revenue outlook to $360–$368 million, implying 9%–12% growth over 2025, while maintaining adjusted EBITDA guidance of $49–$51 million. The quarter also reflected integration of the LymphaTech acquisition and ongoing investment in R&D and commercialization.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.22%
Tags
current report
-
Rhea-AI Summary

The Vanguard Group filed Amendment No. 7 to a Schedule 13G/A reporting zero beneficial ownership of Tactile Systems Technology Inc common stock. The filing states that, following an internal realignment on January 12, 2026 and in reliance on SEC Release No. 34-39538, certain Vanguard subsidiaries will report holdings separately and The Vanguard Group no longer is deemed to beneficially own securities held by those subsidiaries. The filing lists 0 shares and 0% beneficial ownership and is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
annual report
Rhea-AI Summary

Tactile Systems Technology, Inc. is asking stockholders to vote at its May 6, 2026 annual meeting on four main items: electing nine directors, ratifying Grant Thornton LLP as auditor, approving 2025 executive pay on an advisory basis, and amending its charter so directors can be removed with or without cause by a majority vote, consistent with Delaware law.

The board notes that 8 of 9 nominees are independent and that the chair and CEO roles are separated. Executive pay is framed as pay-for-performance: in 2025 the company generated $329.5 million in revenue and $44.8 million in Adjusted EBITDA, resulting in management incentive plan payouts at 115% of target and strong PSU vesting outcomes tied to revenue growth and margin.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Pearson Andrea reported acquisition or exercise transactions in this Form 4 filing.

Tactile Systems Technology Inc. director Andrea Pearson received an equity award of 852 shares of Common Stock. These shares are in the form of restricted stock units granted at no cash cost and will vest in full on the date of the company's 2026 annual meeting of stockholders. Following this grant, Pearson holds 852 shares directly, indicating this filing reflects a routine compensation-related award rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Tactile Systems Technology Inc. director Andrea Pearson filed an initial statement of beneficial ownership as required for insiders. The Form 3 data identifies her role as a director and shows no reported insider transactions or derivative holdings associated with this filing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tactile Systems Technology, Inc. is soliciting proxies for its 2026 Annual Meeting of Stockholders to be held on May 6, 2026, with a record date of March 12, 2026.

The meeting asks holders to elect nine directors, ratify Grant Thornton LLP as auditor for the year ending December 31, 2026, approve an advisory "say-on-pay" for 2025 executive compensation, and approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to permit director removal in a manner consistent with Delaware law. Proxy voting methods and meeting logistics are provided.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Tactile Systems Technology, Inc. appointed Andrea A. Pearson to its board of directors, effective March 9, 2026, and set the board size at nine members. She will serve on the Compliance and Reimbursement Committee and the Nominating and Corporate Governance Committee.

For her board service, Ms. Pearson will receive restricted stock units valued at a pro rata portion of $155,000, granted March 9, 2026, vesting on the date of the Company’s 2026 annual stockholders’ meeting if she remains a director. She will also receive annual cash retainers of $50,000 for board service and $5,000 each for her roles on the two committees, all prorated for her first year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
current report
-
Rhea-AI Summary

Tactile Systems Technology Chief Executive Officer Sheri Louise Dodd reported an open-market sale of 10,993 shares of common stock on February 24, 2026 at a weighted average price of $28.9406 per share. According to the disclosure, these shares were sold to cover taxes associated with the settlement of stock units. After this transaction, Dodd directly owns 243,885 shares of Tactile Systems Technology common stock. The sale was executed in multiple trades with prices ranging from $28.50 to $29.45 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Tactile Systems Technology Inc. chief financial officer Elaine M. Birkemeyer reported an open-market sale of 7,701 shares of common stock on February 24, 2026. The shares were sold to cover taxes associated with the settlement of stock units.

The filing states a weighted average sale price of $28.9417 per share, with individual trades executed between $28.50 and $29.45 per share. After this transaction, Birkemeyer directly holds 134,819 shares of Tactile Systems common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many TACTILE SYSTEMS TECHNOLOGY (TCMD) SEC filings are available on StockTitan?

StockTitan tracks 59 SEC filings for TACTILE SYSTEMS TECHNOLOGY (TCMD), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TACTILE SYSTEMS TECHNOLOGY (TCMD)?

The most recent SEC filing for TACTILE SYSTEMS TECHNOLOGY (TCMD) was filed on May 4, 2026.